Literature DB >> 8552396

Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines.

A M Patel1, L S Incognito, G L Schechter, W J Wasilenko, K D Somers.   

Abstract

Amplification of chromosome 11q13 DNA sequences is detected in approximately 30% of primary head and neck squamous cell carcinomas (HNSCC). The amplified region includes genes for cyclin D1, hst-1, int-2, and more recently, ems-1. Ems-1 encodes an 80/85kd cytoskeletal associated protein termed cortactin, which has been shown to bind F-actin and is a pp60src substrate. We investigated 16 HNSCC cell lines for ems-1 DNA amplification and gene expression by western blotting and immunofluorescence using mAb 4F11. Amplification of ems-1 DNA was detected in 8/16 (50%) cell lines and was related directly to over-expression of cortactin by western blotting and immunofluorescence. Western blotting detected both forms of cortactin, p80 and p85, at equal intensity. Immunofluorescent staining revealed low levels of cortactin localized to the cytoplasm and surface membrane in normal bronchial epithelial cells and tumor cell cultures with single copy ems-1 DNA. In contrast, tumor cell cultures with ems-1 DNA amplification demonstrated intense, homogeneous cortactin cytoplasmic staining. These results suggest that overexpression of p80/85 may be a useful marker to identify 11q13 amplification, a molecular alteration correlated with the presence of lymph node metastasis in head and neck cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8552396

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Proteolysis of cortactin by calpain regulates membrane protrusion during cell migration.

Authors:  Benjamin J Perrin; Kurt J Amann; Anna Huttenlocher
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

2.  Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent.

Authors:  J T Lucas; B P Salimath; M G Slomiany; S A Rosenzweig
Journal:  Oncogene       Date:  2010-05-24       Impact factor: 9.867

3.  The actin regulatory protein HS1 interacts with Arp2/3 and mediates efficient neutrophil chemotaxis.

Authors:  Peter J Cavnar; Kevin Mogen; Erwin Berthier; David J Beebe; Anna Huttenlocher
Journal:  J Biol Chem       Date:  2012-06-07       Impact factor: 5.157

4.  I-BAR protein antagonism of endocytosis mediates directional sensing during guided cell migration.

Authors:  Gabriel A Quinones; Janet Jin; Anthony E Oro
Journal:  J Cell Biol       Date:  2010-04-12       Impact factor: 10.539

Review 5.  [Epigenetic aspects in carcinomas of the head and neck].

Authors:  P Schmezer; C Plass
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

Review 6.  Cortactin signalling and dynamic actin networks.

Authors:  Roger J Daly
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

7.  Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons.

Authors:  Y Du; S A Weed; W C Xiong; T D Marshall; J T Parsons
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

Review 8.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Authors:  Christa Lese Martin; Shalini C Reshmi; Thomas Ried; William Gottberg; John W Wilson; Jaya K Reddy; Poornima Khanna; Jonas T Johnson; Eugene N Myers; Susanne M Gollin
Journal:  Oral Oncol       Date:  2007-08-02       Impact factor: 5.337

9.  Identification of single- and multiple-class specific signature genes from gene expression profiles by group marker index.

Authors:  Yu-Shuen Tsai; Kripamoy Aguan; Nikhil R Pal; I-Fang Chung
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

10.  Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex.

Authors:  S A Weed; A V Karginov; D A Schafer; A M Weaver; A W Kinley; J A Cooper; J T Parsons
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.